Paediatric indications and dosing guidance for advanced targeted treatments in Australia

Patrick D Mahar; Susan J Robertson; David Orchard; Christopher Baker; Peter Foley

doi:10.1111/ajd.14230

Paediatric indications and dosing guidance for advanced targeted treatments in Australia

Australas J Dermatol. 2024 Mar 6. doi: 10.1111/ajd.14230. Online ahead of print.

Authors

Patrick D Mahar^{1

2

3}, Susan J Robertson^{2

4

5}, David Orchard^{2

3}, Christopher Baker^{1

3

6}, Peter Foley^{1

3

6}

Affiliations

¹ Skin Health Institute, Melbourne, Victoria, Australia.
² Department of Dermatology, The Royal Children's Hospital, Melbourne, Victoria, Australia.
³ Faculty of Medicine, Dentistry & Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia.
⁴ Department of Dermatology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
⁵ Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
⁶ Department of Dermatology, St Vincent's Hospital, Melbourne, Victoria, Australia.

PMID: 38445760
DOI: 10.1111/ajd.14230

Abstract

As with adults, paediatric patients may benefit from a number of advanced targeted therapies for inflammatory skin disease. This brief report aims to be an accessible reference tool with respect to regulatory approval and reimbursement of these treatments within Australia.

Keywords: Australia; advanced targeted treatments; alopecia areata; atopic dermatitis; chronic spontaneous urticaria; hidradenitis suppurativa; paediatric; psoriasis.